What do we know about the mechanisms of aromatase inhibitor resistance?
about
Pathways to tamoxifen resistance.Identification of genes for normalization of real-time RT-PCR data in breast carcinomas.The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial.Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway.Molecular characterization of aromatase inhibitor-resistant, tamoxifen-resistant and LTEDaro cell linesGP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cellsLimitations in Adjuvant Breast Cancer Therapy: The Predictive Potential of Pharmacogenetics and Pharmacogenomics.A non-synonymous coding change in the CYP19A1 gene Arg264Cys (rs700519) does not affect circulating estradiol, bone structure or fracture.The transdermal patches for site-specific delivery of letrozole: a new option for breast cancer therapy27-Hydroxycholesterol: the first identified endogenous SERMThe interaction between metabolism, cancer and cardiovascular disease, connected by 27-hydroxycholesterol.An "omics" approach to determine the mechanisms of acquired aromatase inhibitor resistance27-hydroxycholesterol is an endogenous selective estrogen receptor modulatorCharacterization of the weak estrogen receptor alpha agonistic activity of exemestane.Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancerInhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat).New experimental models for aromatase inhibitor resistance.A review of coumarin derivatives in pharmacotherapy of breast cancer.AKT-aro and HER2-aro, models for de novo resistance to aromatase inhibitors; molecular characterization and inhibitor response studiesAn updated review on the efficacy of adjuvant endocrine therapies in hormone receptor-positive early breast cancer.The role of amphiregulin in exemestane-resistant breast cancer cells: evidence of an autocrine loop.27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth.Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth.Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth.The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells.SGK3 sustains ERα signaling and drives acquired aromatase inhibitor resistance through maintaining endoplasmic reticulum homeostasis.Estrogen Receptor Beta-Mediated Modulation of Lung Cancer Cell Proliferation by 27-Hydroxycholesterol
P2860
Q30441001-4A72C768-1E30-43A9-A1E3-096AA4F166EAQ31143419-F4948E56-534B-4B44-9E2E-AC73E1F54C17Q33477635-49BE8CD7-5A17-48A1-B9E1-762F1575755DQ33583914-107AFB36-043A-41B3-A4CF-2CFA30B5FE7DQ33718304-C47A5396-6968-441E-AE44-DCD6BB2C3132Q33928138-4113258E-18A0-4C8B-8FC1-B66838792701Q34095952-A802E594-7E7D-44DA-B09E-1B9C205F95E0Q34106975-86F166E5-E388-408A-BD22-F23B0A58A921Q34280259-39F1C956-BFF5-49AF-B018-6335B1D1C80CQ34762182-DDD07162-66E3-4C38-A765-2B51F9306124Q35012529-93B3E69A-B952-4E06-B58E-3DD6355B3C94Q35075021-B8F1B7EA-BFD1-4AF5-88FA-2689D726064FQ36372645-7C968DB2-EE24-46B7-B662-81CA8F9F96FFQ36415607-F5C1B33A-9924-4651-A560-53BCF39088B7Q36611182-16B6EFA1-3A9A-417F-9706-DFE168B19C7DQ36799721-00229F6B-B6B1-498D-81E6-2AEA412A1374Q36870346-46E3A222-6943-475A-914F-1505238E4F6CQ37169601-1934EE15-F8B7-4A3A-99D5-F58ECC78B7AFQ37247518-B0C7AB18-4EB2-4F5E-B24F-8F232371B601Q37292419-EF5ED127-1AFB-4E12-B81E-6ECE86DE7ECCQ37328397-97E0F0E0-4F16-41E7-9DF7-6FF3179C2EB2Q37632218-9C3886B9-DDA8-4F36-A536-D3DD57ED4063Q38984903-DED17C58-4731-4DAA-BE9C-5CF8D4B3C728Q39664547-66787321-0F2F-4FCC-90F1-1E148DEC8468Q39683553-31D8E3B9-5C23-40F1-8E56-DFEB5FC1EE83Q42154267-DBFB7D7D-3DE2-4EBD-BC79-49B20AE14FCFQ58712246-1488B77B-3E97-4BFC-B684-8CD692DF4C77
P2860
What do we know about the mechanisms of aromatase inhibitor resistance?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
What do we know about the mechanisms of aromatase inhibitor resistance?
@ast
What do we know about the mechanisms of aromatase inhibitor resistance?
@en
type
label
What do we know about the mechanisms of aromatase inhibitor resistance?
@ast
What do we know about the mechanisms of aromatase inhibitor resistance?
@en
prefLabel
What do we know about the mechanisms of aromatase inhibitor resistance?
@ast
What do we know about the mechanisms of aromatase inhibitor resistance?
@en
P2093
P2860
P1476
What do we know about the mechanisms of aromatase inhibitor resistance?
@en
P2093
Selma Masri
Sheryl Phung
Shiuan Chen
Yate-Ching Yuan
P2860
P304
P356
10.1016/J.JSBMB.2006.09.012
P577
2006-10-19T00:00:00Z